Showing results (1381-1390 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|July 1, 2021
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical TrialOsama E Rahma, Greg Yothers, Theodore S Hong, et al.
JAMA Oncology|June 24, 2021
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical TrialZhouguang Hui, Yu Men, Chen Hu, et al.
JAMA Oncology|June 24, 2021
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical TrialThomas Hatschek, Theodoros Foukakis, Judith Bjöhle, et al.
JAMA Oncology|July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for CancerTal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
JAMA Oncology|July 8, 2021
Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical TrialAndrew J Wagner, Paul L Severson, Anthony F Shields, et al.
JAMA Oncology|July 8, 2021
Application of Information Technology to Clinical Trial Evaluation and Enrollment: A ReviewMitchell S von Itzstein, Melanie Hullings, Helen Mayo, et al.
JAMA Oncology|May 19, 2022
Association of 5α-Reductase Inhibitors With Prostate Cancer MortalityLars Björnebo, Tobias Nordström, Andrea Discacciati, et al.
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
JAMA Oncology|April 20, 2023
Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-analysisMichael Baboudjian, Bastien Gondran-Tellier, Charles Dariane, et al.
JAMA Oncology|April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical TrialSamuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
Pageof 162